Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tata Communications enhances InstaCC™ Platform with digital features 2022-08-08 18:53
Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device 2022-08-08 16:45
Fashion meets Technology: Uplive and Hekka Bring Innovative Concepts to Miami Swim Week Runway 2022-08-08 16:06
What's Next for Autonomous Driving? Mouser's Empowering Innovation Together Explores AI-Based Driver Monitoring 2022-08-08 15:54
Tech Data Distribution (Hong Kong) enters into Strategic Collaboration with Tencent Cloud in Hong Kong and Macau 2022-08-08 15:45
TCL Reaffirms its Leadership in Mini LED TVs in 2022 2022-08-08 15:00
AirCarbon Exchange Offsets Emissions Through to December 2023 2022-08-08 14:00
BEYOND Expo 2022 Early Bird Booth Registration - Ending August 31st 2022-08-08 13:05
SOHU.COM REPORTS SECOND QUARTER 2022 UNAUDITED FINANCIAL RESULTS 2022-08-08 13:00
Jaewoo Lee Appointed Ropes & Gray's Seoul Managing Partner 2022-08-08 13:00
Chengdu Cultural Tourism Video Exhibition "East Asian Cultural Capital - Park City under the Snowy Mountains" Opens in Seoul 2022-08-08 12:42
Baidu Granted China's First-Ever Permits for Commercial Fully Driverless Ride-Hailing Services 2022-08-08 12:06
Join our EV Revolution and Keep the City Green - Drive lah 2022-08-08 11:45
Forrester's Future Of Jobs Forecast: 63 Million Jobs In APAC Will Be Lost To Automation By 2040 2022-08-08 10:45
Qmed Asia launches Qmed GO "Mini Clinics" to Solve Rising Employee Healthcare Costs 2022-08-08 10:15
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition 2022-08-08 10:00
DDPAI Z50 4K DUAL DASH CAM LAUNCH 2022-08-08 10:00
BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs 2022-08-08 09:06
ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation 2022-08-08 08:30
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors 2022-08-08 08:10
1 956 957 958 959 960 3594